title: [Clinical trial of pregnancy terminations in 353 patients where amenorrhea was present for less than 49 days by 600 mg of RU 486 (administered orally) and 500 mg of sulprostone (Nalador) administered intramuscularly].
authors.forename: E
authors.initials: E
authors.lastname: Aubeny
authors.forename: A
authors.initials: A
authors.lastname: Bureau
authors.forename: P
authors.initials: P
authors.lastname: Gabeaud
authors.forename: I
authors.initials: I
authors.lastname: Heard
authors.forename: M
authors.initials: M
authors.lastname: Eucher
authors.forename: T
authors.initials: T
authors.lastname: Husson
authors.forename: L
authors.initials: L
authors.lastname: Meng
authors.forename: S
authors.initials: S
authors.lastname: Riotte
mesh_terms: D000019:Abortifacient Agents; D000023:Abortion Applicants; D000028:Abortion, Induced; D001695:Biology; D019049:Developed Countries; D004703:Endocrine System; D005060:Europe; D005193:Family Planning Services; D005602:France; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D010827:Physiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012098:Reproduction
chemical_list: D000019:Abortifacient Agents; D006727:Hormone Antagonists; D006728:Hormones; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D015735:Mifepristone
keywords: Abortifacient Agents; Abortion Seekers; Abortion, Drug Induced; Abortion, Induced; Biology; Developed Countries; Endocrine System; Europe; Family Planning; Fertility Control, Postconception; France; Hormone Antagonists; Hormones; Mediterranean Countries; Physiology; Pregnancy; Pregnancy, First Trimester; Prostaglandins; Prostaglandins, Synthetic--administraction and dosage; Reproduction; Ru-486; Western Europe